कृपया अन्य खोज का प्रयास करें
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company’s lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Quan Dong Nguyen | - | 2022 | Member of Scientific Advisory Board |
Peter K. Kaiser | - | 2022 | Member of Scientific Advisory Board |
Kuldev Singh | - | - | Member of Scientific Advisory Board |
Anat Loewenstein | - | 2022 | Member of Scientific Advisory Board |
Pablo Villoslada | - | 2022 | Member of Scientific Advisory Board |
Anthony A. Rosenberg | 71 | 2018 | Independent Chairman |
Riad Sherif | 56 | 2017 | CEO & Director |
Martijn Kleijwegt | 69 | 2023 | Independent Director |
Lionel Carnot | 57 | 2017 | Independent Director |
Christophe Baudouin | 63 | 2022 | Member of Scientific Advisory Board |
Arshad M. Khanani | - | 2022 | Chair of Retina Scientific Advisory Board |
Christina M. Ackermann | 59 | 2023 | Independent Director |
Pravin U. Dugel | 60 | 2023 | Independent Director |
Eric D. Donnenfeld | 68 | - | Chair of Cornea Scientific Advisory Board |
David S. Boyer | - | 2024 | Member of Scientific Advisory Board |
Geraldine O'Keeffe | - | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है